SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-10-000361
Filing Date
2010-05-18
Accepted
2010-05-18 17:28:54
Documents
2
Group Members
ADAM STERNAM INVESTMENT PARTNERS, LLCBAM CAPITAL, LLCBAM MANAGEMENT, LLCBAM OPPORTUNITY FUND SPV, LLCHAL MINTZMARK FRIEDMANROSS BERMAN

Document Format Files

Seq Description Document Type Size
1 prana_sch13ga6.htm SC 13G/A 214572
2 prana_sch13ga6ex1.htm EX-1 16539
  Complete submission text file 0000929638-10-000361.txt   233288
Mailing Address LEVEL 2 369 ROYAL PARADE PARKVILLE, VICTORIA C3 3052
Business Address LEVEL 2 369 ROYAL PARADE PARKVILLE, VICTORIA C3 3052 61-3-9349-4906
PRANA BIOTECHNOLOGY LTD (Subject) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-79901 | Film No.: 10843541
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005
Business Address 44 WALL STREET SUITE 1603 NEW YORK NY 10005 646-307-4503
BAM Opportunity Fund, L.P. (Filed by) CIK: 0001433768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A